Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Francesca Gatta
Skin Toxicity and Quality of Life During Treatment With Panitumumab for RAS Wild-Type Metastatic Colorectal Carcinoma: Results From Three Randomised Clinical Trials
Quality of Life Research
Environmental
Public Health
Occupational Health
Physicians’ Preferences for Bone Metastases Treatments in France, Germany and the United Kingdom
BMC Health Services Research
Health Policy
Related publications
Relationship Between Tumour Response and Tumour-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials
Clinical Colorectal Cancer
Oncology
Gastroenterology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Metastatic Colorectal Carcinoma: Response to Panitumumab
Journal of the Bahrain Medical Society
Impact of Primary Tumour Location on Second- Or Later-Line Treatment Outcomes in Patients With RAS Wild-Type Metastatic Colorectal Cancer and in All Lines of Treatment in Patients With RAS Mutations in Four Randomised Panitumumab Studies
Clinical Colorectal Cancer
Oncology
Gastroenterology
Randomized Controlled Trial on the Skin Toxicity of Panitumumab in Japanese Patients With Metastatic Colorectal Cancer: HGCSG1001 Study; J-Stepp
Future Oncology
Medicine
Cancer Research
Oncology
Health-Related Quality of Life and Colorectal Cancer-Specific Symptoms in Patients With Chemotherapy-Refractory Metastatic Disease Treated With Panitumumab
International Journal of Colorectal Disease
Gastroenterology
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-Line Cetuximab and Irinotecan
JAMA Oncology
Cancer Research
Oncology
Sequential HER2 Blockade as Effective Therapy in Chemorefractory, HER2 Gene-Amplified, RAS Wild-Type, Metastatic Colorectal Cancer: Learning From a Clinical Case
ESMO Open
Cancer Research
Oncology
Magnetic Resonance Imaging as an Early Indicator of Clinical Outcome in Patients With Metastatic Colorectal Carcinoma Treated With Cetuximab or Panitumumab
Clinical Colorectal Cancer
Oncology
Gastroenterology
